Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature

Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature

Abstract Background Multicentric Castleman’s disease is a life-threatening disorder involving a systemic inflammatory response and multiple organ failure caused by the overproduction of interleukin-6. Although renal complications of Castleman’s disease include AA amyloidosis, thrombotic microangiopa...

Full description

Bibliographic Details
Main Authors: Ryosuke Saiki, Kan Katayama, Yosuke Hirabayashi, Keiko Oda, Mika Fujimoto, Tomohiro Murata, Ayako Nakajima, Kaoru Dohi
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Nephrology
Subjects:
Castleman’s disease - membranous nephropathy
Proteinuria - tocilizumab
Online Access:https://doi.org/10.1186/s12882-021-02423-w

Internet

https://doi.org/10.1186/s12882-021-02423-w

Similar Items